Fig. 3.
Relapse rates of APL and non-APL patients with AML according to the MRD levels.
High risk (MRD: greater than 10−2 LAP+ cells), intermediate risk (MRD: 10−3 to 10−2LAP+ cells), low risk (MRD: fewer than 10−3LAP+ cells); and very low risk (fewer than 10−4 LAP+ cells).
